|
NFAT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.761700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.505700E-02 |
| Normal-vs-Stage2 |
5.930200E-01 |
| Normal-vs-Stage3 |
9.688800E-01 |
| Normal-vs-Stage4 |
1.773640E-01 |
| Stage1-vs-Stage2 |
6.821200E-01 |
| Stage1-vs-Stage3 |
3.276200E-01 |
| Stage1-vs-Stage4 |
2.231700E-02 |
| Stage2-vs-Stage3 |
6.798000E-01 |
| Stage2-vs-Stage4 |
2.650000E-01 |
| Stage3-vs-Stage4 |
3.206200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.789600E-02 |
| Normal-vs-AfricanAmerican |
4.492200E-01 |
| Normal-vs-Asian |
8.231200E-01 |
| Caucasian-vs-AfricanAmerican |
3.212600E-01 |
| Caucasian-vs-Asian |
5.484000E-01 |
| AfricanAmerican-vs-Asian |
6.604600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.315900E-02 |
| Normal-vs-Female |
1.387810E-01 |
| Male-vs-Female |
8.326400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.770000E-01 |
| Normal-vs-Extreme_Weight |
2.861800E-01 |
| Normal-vs-Obese |
1.362010E-02 |
| Normal-vs-Extreme_Obese |
7.562200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.232200E-01 |
| Normal_Weight-vs-Obese |
9.240000E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.199800E-01 |
| Extreme_Weight-vs-Obese |
1.133780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.573000E-01 |
| Obese-vs-Extreme_Obese |
3.691400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.053800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.577000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.921800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.778400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.963400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.371200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.167900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.969700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.32689999999369E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.901570E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.960600E-04 |
| Normal-VS-Type2 PRCC |
2.956500E-02 |
| Normal-VS-KIRP CIMP |
8.175200E-01 |
| Normal-VS-Unclassified PRCC |
2.653200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.91449994641135E-09 |
| Type1 PRCC-VS-KIRP CIMP |
3.365800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.455800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.888000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.759970E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.752400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.742400E-01 |
| Normal-vs-N1 |
9.027200E-01 |
| Normal-vs-N2 |
2.758100E-04 |
| N0-vs-N1 |
8.569000E-01 |
| N0-vs-N2 |
5.704100E-03 |
| N1-vs-N2 |
4.526100E-02 |
|
|
